<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T07:28:58Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3459082" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:3459082</identifier>
        <datestamp>2012-10-09</datestamp>
        <setSpec>elsevierwt</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Lancet Infect Dis</journal-id>
              <journal-id journal-id-type="iso-abbrev">Lancet Infect Dis</journal-id>
              <journal-title-group>
                <journal-title>The Lancet. Infectious Diseases</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1473-3099</issn>
              <issn pub-type="epub">1474-4457</issn>
              <publisher>
                <publisher-name>Elsevier Science ;, The Lancet Pub. Group</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC3459082</article-id>
              <article-id pub-id-type="pmcid">PMC3459082</article-id>
              <article-id pub-id-type="pmc-uid">3459082</article-id>
              <article-id pub-id-type="pmid">22878023</article-id>
              <article-id pub-id-type="pii">S1473-3099(12)70144-5</article-id>
              <article-id pub-id-type="doi">10.1016/S1473-3099(12)70144-5</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cárcamo</surname>
                    <given-names>César P</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff1" ref-type="aff">a</xref>
                  <xref rid="aff3" ref-type="aff">c</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Campos</surname>
                    <given-names>Pablo E</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff1" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>García</surname>
                    <given-names>Patricia J</given-names>
                  </name>
                  <degrees>Prof</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="aff1" ref-type="aff">a</xref>
                  <xref rid="aff3" ref-type="aff">c</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hughes</surname>
                    <given-names>James P</given-names>
                  </name>
                  <degrees>Prof</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="aff5" ref-type="aff">e</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Garnett</surname>
                    <given-names>Geoff P</given-names>
                  </name>
                  <degrees>Prof</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="aff2" ref-type="aff">b</xref>
                  <xref rid="aff7" ref-type="aff">g</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Holmes</surname>
                    <given-names>King K</given-names>
                  </name>
                  <degrees>Prof</degrees>
                  <degrees>PhD</degrees>
                  <email>kkh@u.washington.edu</email>
                  <xref rid="aff3" ref-type="aff">c</xref>
                  <xref rid="aff4" ref-type="aff">d</xref>
                  <xref rid="aff6" ref-type="aff">f</xref>
                  <xref rid="cor1" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <collab>for the Peru PREVEN study team</collab>
                  <xref rid="fn1" ref-type="fn">†</xref>
                </contrib>
                <aff id="aff1"><label>a</label>Epidemiology, STD, and HIV Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru</aff>
                <aff id="aff2"><label>b</label>Imperial College, London, London, UK</aff>
                <aff id="aff3"><label>c</label>Center for AIDS and STD, University of Washington, Seattle, WA, USA</aff>
                <aff id="aff4"><label>d</label>Department of Global Health, University of Washington, Seattle, WA, USA</aff>
                <aff id="aff5"><label>e</label>Department of Biostatistics, University of Washington, Seattle, WA, USA</aff>
                <aff id="aff6"><label>f</label>Department of Medicine, University of Washington, Seattle, WA, USA</aff>
                <aff id="aff7"><label>g</label>Bill &amp; Melinda Gates Foundation, Seattle, WA, USA</aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><label>*</label>Correspondence to: Prof King K Holmes, Department of Global Health, University of Washington, 325 Ninth Avenue, Box 359931/13NJ1335, Seattle, WA 98104-2499, USA <email>kkh@u.washington.edu</email></corresp>
                <fn id="fn1">
                  <label>†</label>
                  <p>Members listed at the end of the report</p>
                </fn>
              </author-notes>
              <pub-date pub-type="pmc-release">
                <day>1</day>
                <month>10</month>
                <year>2012</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
              <pub-date pub-type="ppub">
                <month>10</month>
                <year>2012</year>
              </pub-date>
              <volume>12</volume>
              <issue>10</issue>
              <fpage>765</fpage>
              <lpage>773</lpage>
              <permissions>
                <copyright-statement>© 2012 Elsevier Ltd. All rights reserved.</copyright-statement>
                <copyright-year>2012</copyright-year>
                <copyright-holder>Elsevier Ltd</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</ext-link>, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.</license-p>
                </license>
              </permissions>
              <related-article related-article-type="article-reference" id="d35e12" ext-link-type="doi" xlink:href="10.1016/S1473-3099(12)70176-7"/>
              <abstract>
                <title>Summary</title>
                <sec>
                  <title>Background</title>
                  <p>We assessed prevalences of seven sexually transmitted infections (STIs) in Peru, stratified by risk behaviours, to help to define care and prevention priorities.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>In a 2002 household-based survey of the general population, we enrolled randomly selected 18–29-year-old residents of 24 cities with populations greater than 50 000 people. We then surveyed female sex workers (FSWs) in these cities. We gathered data for sexual behaviour; vaginal specimens or urine for nucleic acid amplification tests for <italic>Neisseria gonorrhoeae</italic>, <italic>Chlamydia trachomatis</italic>, and <italic>Trichomonas vaginalis</italic>; and blood for serological tests for syphilis, HIV, and (in subsamples) herpes simplex virus 2 (HSV2) and human T-lymphotropic virus. This study is a registered component of the PREVEN trial, number ISRCTN43722548.</p>
                </sec>
                <sec>
                  <title>Findings</title>
                  <p>15 261 individuals from the general population and 4485 FSWs agreed to participate in our survey. Overall prevalence of infection with HSV2, weighted for city size, was 13·5% in men, 13·6% in women, and 60·6% in FSWs (all values in FSWs standardised to age composition of women in the general population). The prevalence of <italic>C trachomatis</italic> infection was 4·2% in men, 6·5% in women, and 16·4% in FSWs; of <italic>T vaginalis</italic> infection was 0·3% in men, 4·9% in women, and 7·9% in FSWs; and of syphilis was 0·5% in men, 0·4% in women, and 0·8% in FSWs. <italic>N gonorrhoeae</italic> infection had a prevalence of 0·1% in men and women, and of 1·6% in FSWs. Prevalence of HIV infection was 0·5% in men and FSWs, and 0·1% in women. Four (0·3%) of 1535 specimens were positive for human T-lymphotropic virus 1. In men, 65·0% of infections with HIV, 71·5% of <italic>N gonorrhoeae</italic>, and 41·4% of HSV2 and 60·9% of cases of syphilis were in the 13·3% who had sex with men or unprotected sex with FSWs in the past year. In women from the general population, 66·7% of infections with HIV and 16·7% of cases of syphilis were accounted for by the 4·4% who had been paid for sex by any of their past three partners.</p>
                </sec>
                <sec>
                  <title>Interpretation</title>
                  <p>Defining of high-risk groups could guide targeting of interventions for communicable diseases—including STIs—in the general Peruvian population.</p>
                </sec>
                <sec>
                  <title>Funding</title>
                  <p>Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative and US National Institutes of Health.</p>
                </sec>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec id="cesec10">
              <title>Introduction</title>
              <p id="para50">National population-based surveys of sexually transmitted infections (STIs) and sexual behaviours provide estimates of population-specific prevalences, trends, and determinants.<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref> However, most national surveys have been restricted to few STIs and sexual behaviours,<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib4" ref-type="bibr">4</xref>, <xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref> or to rural populations.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> We present results of surveys of STI prevalences in middle-sized cities in Peru, and of patterns of sexual behaviours in random household samples of young adult residents and samples of female sex workers (FSWs).</p>
            </sec>
            <sec id="cesec20">
              <title>Methods</title>
              <sec id="cesec30">
                <title>Study design and participants</title>
                <p id="para60">In 2002, we selected 30 Peruvian cities with populations greater than 50 000 people. We excluded Lima because of its size, two other cities because of their proximity to Lima, and three cities involved in a separate prevention study of STIs and HIV—leaving 24 cities for inclusion in our study. The study sampling frame of the general-population survey used the 1999–2000 precensus household database of the Peruvian National Institute of Statistics and Informatics (INEI). We defined sampling units (clusters) as roughly 40 households, providing about ten eligible participants per cluster. For each city, we assigned a random number to every cluster, sorted them numerically, and selected the top 108 clusters (36 each for three fieldworkers). Three of the 2592 neighbourhood clusters randomly selected for this survey were judged to be dangerous (interviewers would be at risk of being attacked or robbed) and not surveyed.</p>
                <p id="para70">Fieldwork for the general-population survey took place between Aug 15, and Nov 15, 2002, in nine 10-day periods. Fieldworkers updated household lists of men and women aged 18–29 years who had lived in the city for at least the past 6 months in every cluster. In clusters with more than ten households containing young people, a table of random numbers for selection of households was used to obtain a random sample of ten. Four clusters (40 suitable households) were covered per period by each fieldworker. When several household members met our inclusion criteria, the individual with the most recent birthday was selected, and scheduled for interview to confirm eligibility and obtain informed consent. When eligibility was not subsequently confirmed, the eligible person with next most recent birthday was selected. Recruitment continued until the quota of 250 women and 250 men per city was reached or exceeded. Interviewers wore white gowns with INEI and PREVEN logos, and carried backpacks and coolers containing frozen acrylamide gel bags.</p>
                <p id="para80">Between Nov 7, 2002, and April 22, 2003, local teams used key informants (peer FSWs, FSW clients, and clinics for FSWs) to map sex work venues in every city, such as brothels, bars, discos, hotels, toll booths, massage parlours, parks, and streets. The teams selected the order for venue visits with random numbers until all FSWs identified were recruited, or 200 FSWs had been recruited per city, primarily from these venues (80%) and also from local government clinics serving FSWs (20%). All eligible consenting women aged 14 years or older offering sex services identified during venue or clinic visits were invited to participate. FSW surveyors visited new venues when open for sex services until the city quota of 200 was reached or exceeded, or the survey period ended.</p>
                <p id="para90">The research team obtained written approval from the Peruvian Ministry of Health, and verbal approval from health directors of all regions surveyed to use Ministry of Health laboratories and counselling staff for the survey. Participants provided verbal informed consent, without personal identifiers. Institutional review boards at the University of Washington (Seattle, WA, USA), the Universidad Peruana Cayetano Heredia (Lima, Peru), and the US Naval Medical Research Unit Number 6 (NAMRU-6; Lima, Peru) approved the protocol, consent forms, and instruments. The institutional review boards approved inclusion of girls aged 14–17 years involved in sex work because they were financially independent from their parents, sexually active, and as minors were often excluded from Ministry of Health clinical services for FSWs. Young adult survey participants received study caps and T-shirts; FSW survey participants received free condoms.</p>
              </sec>
              <sec id="cesec40">
                <title>Procedures</title>
                <p id="para100">For general-population surveys, female health professionals (ie, nurses, midwives, and medical doctors) with venepuncture experience took a 9-day course of lectures, demonstrations, and supervised role-playing of interviewing, specimen collection and coding, ethics, STIs, map interpretation, participant selection, and informed consent procedures. Seven regional coordinators, a national supervisor, three interviewers, and one supervisor for every city were selected on the basis of course performance. We similarly trained and selected interviewers and supervisors for FSW surveys; every field team included an FSW peer-educator, a counsellor–interviewer, and a physician or midwife.</p>
                <p id="para110">Laboratory technicians designated by local health authorities received training in specimen processing, labelling, storage, shipping, and <italic>Trichomonas vaginalis</italic> cultures. Staff from the University of Washington provided supervision, quality assurance, and Gen-Probe Aptima Combo 2 assays for quality control.</p>
                <p id="para120">Face-to-face interviews addressed demographics, household characteristics, travel and migration, labour, and marriage. Subsequent private, self-administered questionnaires of participants from the general population explored sexual behaviours; completed questionnaires were sealed in envelopes, and placed into locked voting bags<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> to ensure anonymity.</p>
                <p id="para130">Men from the general population provided 15 mL first-void urine and the women provided self-obtained vaginal swabs (SOVS), with one polyester–plastic swab and then two cotton–wooden swabs. Interviewers promptly placed polyester SOVS into cryovials, and inoculated the first cotton swab into an InPouch TV system (BioMed Diagnostics, White City, OR, USA) for <italic>T vaginalis</italic> culture. Women from the general population who did not provide SOVS were asked for 15 mL first-void urine samples. For FSWs, a polyester cervical swab and two cotton vaginal swabs were obtained during speculum examination. Venous blood was collected from consenting participants. A subset of the general-population participants (100% of individuals with a cohabiting sex partner and 10% random sample of others) and an 8·5% random sample (size of sample determined by number of test kits available) of FSWs underwent testing for herpes simplex virus 2 (HSV2). To obtain the random samples, we assigned random numbers to individuals from the general population and to FSWs who gave blood, ordered them numerically, and selected individuals from the top of the list.</p>
                <p id="para140">Urine, polyester swabs, and blood were transported inside coolers to the local laboratory within 4 h of collection. <italic>T vaginalis</italic> cultures were transported at ambient temperature. Consent forms, face-to-face questionnaires, referral cards, and samples were labelled with alphanumeric codes and barcodes. Self-completed questionnaires were labelled with bar codes.</p>
                <p id="para150">Local laboratory staffing was scheduled whenever specimens were obtained; urine and serum were promptly divided into aliquots in vials and frozen at −20°C. Frozen urine and serum aliquots and polyester swabs were sent weekly to Lima laboratories in Styrofoam coolers wrapped in metal. <italic>T vaginalis</italic> culture results were sent to Lima monthly.</p>
                <p id="para160">Temperature within coolers on arrival in Lima was usually less than 0°C and never more than 1°C. 1 mL of 2-sucrose phosphate medium<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> was added to vials containing dry polyester swabs, which was then mixed, divided into aliquots, and stored at −20°C until testing by Cobas Amplicor for <italic>Neisseria gonorrhoeae</italic> and <italic>Chlamydia trachomatis</italic>. All specimens positive for <italic>N gonorrhoeae</italic>, samples of specimens positive for <italic>C trachomatis</italic>, and all specimens with equivocal results per manufacturer's instructions went to the University of Washington for confirmatory tests with the Aptima Combo 2 assay. Specimens in 2-sucrose-phosphate also underwent Aptima testing for <italic>T vaginalis</italic>. We tested specimens for syphilis serology with RPR nosticon II (Organon Teknika, Boxtel, Netherlands), judging results positive when rapid plasma reagin measurements were 1:8 or more, with confirmation by Serodia TPPA (Fujirebio, Tokyo, Japan). We used Uni-Form II Ag/Ab (Biomerieux-Vironostika, Durham, NC, USA) ELISA for HIV serology and New LAV Blot I (Bio-Rad, Hercules, CA, USA) for confirmation. The first 1530 sera specimens (number determined by number of test kits available) from the general population were tested for human T-lymphotropic virus seropositivity by ELISA (Vironostika, Durham, NC, USA), with western blot 2·4 (Genelabs Diagnostics, Science Park, Singapore). We used ELISA testing for HSV2 (HerpeSelect HSV-2, Focus Technologies, Cypress, CA, USA); index values of 3·5 or more were deemed positive. All diagnostic tests were done in accordance with the manufacturer's recommended procedures.</p>
                <p id="para170">Participants who provided specimens received HIV counselling booklets.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Results for syphilis, <italic>C trachomatis</italic>, <italic>N gonorrhoeae</italic>, HIV, and <italic>T vaginalis</italic> culture were printed and distributed to predefined local STI clinics to which participants from the general population had been referred. To distribute results to FSWs, clinic counsellors returned to sex work venues. Results, counselling, and treatment for STIs, and referral for care for patients with HIV (after informed consent) were provided anonymously by matching sample codes with each participant's referral card code.</p>
              </sec>
              <sec id="cesec50">
                <title>Statistical analysis</title>
                <p id="para180">Face-to-face questionnaires were checked daily for consistency and completeness, corrected locally when necessary, and then sent to Lima for data entry. Self-completed questionnaires were sent to Lima without local validation to ensure confidentiality. We entered general-population data with an SQL program. All FSW survey data were double entered with EpiInfo (version 3.3). All self-completed questionnaires and 5% of face-to-face questionnaires were double entered. We used 5% of face-to-face questionnaires to allow us to test the hypothesis that the frequency of errors in any one variable was less than 2% with 95% CIs. For face-to-face questionnaires, error frequency was less than 1%.</p>
                <p id="para190">We analysed data with STATA (version 8.2). To account for differences in general-population sampling probabilities in cities of various population sizes, we present weighted prevalences when totalling prevalences of STIs for all cities combined. City-level estimates of general-population prevalences of HSV2 are weighted to account for test subsampling. To account for differences in age composition of FSWs and women from the general population surveyed, we calculated age-standardised STI prevalences for FSWs by excluding those younger than 18 years or older than 29 years, and weighted remaining FSW data in line with proportions of women from the general population in every age category. We calculated prevalence ratios with an unweighted generalised linear model with log link and adjustment for clustering and age. We calculated p values from the same regression or by exact logistic regression for very rare diseases.</p>
                <p id="para200">This study is a registered component of the PREVEN trial, number ISRCTN43722548.</p>
              </sec>
              <sec id="cesec60">
                <title>Role of the funding source</title>
                <p id="para210">The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all data in the study and had final responsibility for the decision to submit for publication.</p>
              </sec>
            </sec>
            <sec id="cesec70">
              <title>Results</title>
              <p id="para220">Of 15 261 individuals from the general population who agreed to participate in our survey (<xref rid="tbl1" ref-type="table">table 1</xref>), 43 (0·3%) left the self-completed questionnaire blank. 11 483 individuals (75·2%) provided blood. Of 7486 men, 6500 (86·8%) provided urine. Of 7775 women, 5924 (76·2%) provided SOVS and 588 others (7·6%) provided urine. 4485 FSWs participated. The FSW participation rate was 95% in the five cities where it was measured. Questionnaire data are available from 4413 (98·4%) FSWs, blood from 4428 (98·7%), and cervical swabs (for <italic>C trachomatis</italic> and <italic>N gonorrhoeae</italic>) and vaginal swabs (for <italic>T vaginalis)</italic> from 4280 (95·4%).<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Participation in the general population survey by city</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th align="left"><bold>Households selected</bold></th><th align="left"><bold>Households excluded</bold><xref rid="tbl1fn1" ref-type="table-fn">*</xref></th><th align="left"><bold>Selected person absent</bold></th><th colspan="5" align="left"><bold>Selected person identified and invited to participate</bold><hr/></th></tr><tr><th/><th/><th/><th/><th align="left"><bold>Total</bold></th><th align="left"><bold>Refused</bold></th><th colspan="3" align="left"><bold>Accepted</bold><hr/></th></tr><tr><th/><th/><th/><th/><th/><th/><th align="left">Total</th><th align="left">Provided questionnaire data</th><th align="left">Provided biological samples</th></tr></thead><tbody><tr><td align="left">Arequipa</td><td align="left">970</td><td align="left">113 (12%)</td><td align="left">11</td><td align="left">846</td><td align="left">82 (10%)</td><td align="left">764 (90%)</td><td align="left">764</td><td align="left">607 (79%)</td></tr><tr><td align="left">Ayacucho</td><td align="left">969</td><td align="left">259 (27%)</td><td align="left">13</td><td align="left">697</td><td align="left">40 (6%)</td><td align="left">657 (94%)</td><td align="left">657</td><td align="left">538 (82%)</td></tr><tr><td align="left">Barranca</td><td align="left">990</td><td align="left">168 (17%)</td><td align="left">6</td><td align="left">816</td><td align="left">114 (14%)</td><td align="left">702 (86%)</td><td align="left">702</td><td align="left">537 (76%)</td></tr><tr><td align="left">Cajamarca</td><td align="left">995</td><td align="left">197 (20%)</td><td align="left">3</td><td align="left">795</td><td align="left">131 (16%)</td><td align="left">664 (84%)</td><td align="left">664</td><td align="left">518 (78%)</td></tr><tr><td align="left">Cerro de Pasco</td><td align="left">765</td><td align="left">106 (14%)</td><td align="left">2</td><td align="left">657</td><td align="left">43 (7%)</td><td align="left">614 (93%)</td><td align="left">614</td><td align="left">566 (92%)</td></tr><tr><td align="left">Chimbote</td><td align="left">980</td><td align="left">261 (27%)</td><td align="left">21</td><td align="left">698</td><td align="left">26 (4%)</td><td align="left">672 (96%)</td><td align="left">672</td><td align="left">564 (84%)</td></tr><tr><td align="left">Chincha</td><td align="left">925</td><td align="left">176 (19%)</td><td align="left">0</td><td align="left">749</td><td align="left">30 (4%)</td><td align="left">719 (96%)</td><td align="left">719</td><td align="left">523 (73%)</td></tr><tr><td align="left">Cusco</td><td align="left">995</td><td align="left">334 (34%)</td><td align="left">1</td><td align="left">660</td><td align="left">56 (8%)</td><td align="left">604 (92%)</td><td align="left">604</td><td align="left">563 (93%)</td></tr><tr><td align="left">Huancayo</td><td align="left">971</td><td align="left">207 (21%)</td><td align="left">19</td><td align="left">745</td><td align="left">67 (9%)</td><td align="left">678 (91%)</td><td align="left">678</td><td align="left">537 (79%)</td></tr><tr><td align="left">Huanuco</td><td align="left">969</td><td align="left">288 (30%)</td><td align="left">2</td><td align="left">679</td><td align="left">61 (9%)</td><td align="left">618 (91%)</td><td align="left">618</td><td align="left">516 (83%)</td></tr><tr><td align="left">Huaraz</td><td align="left">878</td><td align="left">154 (18%)</td><td align="left">14</td><td align="left">710</td><td align="left">76 (11%)</td><td align="left">634 (89%)</td><td align="left">634</td><td align="left">539 (85%)</td></tr><tr><td align="left">Ica</td><td align="left">866</td><td align="left">281 (32%)</td><td align="left">1</td><td align="left">584</td><td align="left">20 (3%)</td><td align="left">564 (97%)</td><td align="left">564</td><td align="left">521 (92%)</td></tr><tr><td align="left">Ilo</td><td align="left">903</td><td align="left">110 (12%)</td><td align="left">59</td><td align="left">734</td><td align="left">152 (21%)</td><td align="left">582 (79%)</td><td align="left">582</td><td align="left">550 (94%)</td></tr><tr><td align="left">Iquitos</td><td align="left">780</td><td align="left">188 (24%)</td><td align="left">0</td><td align="left">592</td><td align="left">11 (2%)</td><td align="left">581 (98%)</td><td align="left">581</td><td align="left">531 (91%)</td></tr><tr><td align="left">Juliaca</td><td align="left">954</td><td align="left">250 (26%)</td><td align="left">5</td><td align="left">699</td><td align="left">91 (13%)</td><td align="left">608 (87%)</td><td align="left">608</td><td align="left">572 (94%)</td></tr><tr><td align="left">Pisco</td><td align="left">885</td><td align="left">242 (27%)</td><td align="left">3</td><td align="left">640</td><td align="left">59 (9%)</td><td align="left">581 (91%)</td><td align="left">580</td><td align="left">546 (94%)</td></tr><tr><td align="left">Piura</td><td align="left">892</td><td align="left">213 (24%)</td><td align="left">5</td><td align="left">674</td><td align="left">33 (5%)</td><td align="left">641 (95%)</td><td align="left">641</td><td align="left">558 (87%)</td></tr><tr><td align="left">Pucallpa</td><td align="left">993</td><td align="left">348 (35%)</td><td align="left">3</td><td align="left">642</td><td align="left">32 (5%)</td><td align="left">610 (95%)</td><td align="left">610</td><td align="left">552 (90%)</td></tr><tr><td align="left">Puno</td><td align="left">989</td><td align="left">234 (24%)</td><td align="left">14</td><td align="left">741</td><td align="left">81 (11%)</td><td align="left">660 (89%)</td><td align="left">660</td><td align="left">583 (88%)</td></tr><tr><td align="left">Sullana</td><td align="left">984</td><td align="left">197 (20%)</td><td align="left">12</td><td align="left">775</td><td align="left">124 (16%)</td><td align="left">651 (84%)</td><td align="left">651</td><td align="left">524 (80%)</td></tr><tr><td align="left">Tacna</td><td align="left">861</td><td align="left">215 (25%)</td><td align="left">0</td><td align="left">646</td><td align="left">48 (7%)</td><td align="left">598 (93%)</td><td align="left">598</td><td align="left">552 (92%)</td></tr><tr><td align="left">Talara</td><td align="left">967</td><td align="left">182 (19%)</td><td align="left">29</td><td align="left">756</td><td align="left">192 (25%)</td><td align="left">564 (75%)</td><td align="left">564</td><td align="left">522 (92%)</td></tr><tr><td align="left">Tarapoto</td><td align="left">899</td><td align="left">236 (26%)</td><td align="left">5</td><td align="left">658</td><td align="left">19 (3%)</td><td align="left">639 (97%)</td><td align="left">639</td><td align="left">544 (85%)</td></tr><tr><td align="left">Tumbes</td><td align="left">956</td><td align="left">282 (29%)</td><td align="left">0</td><td align="left">674</td><td align="left">18 (3%)</td><td align="left">656 (97%)</td><td align="left">656</td><td align="left">536 (82%)</td></tr><tr><td align="left">Total</td><td align="left">22 336</td><td align="left">5241 (23%)</td><td align="left">228</td><td align="left">16 867</td><td align="left">1606 (10%)</td><td align="left">15 261 (90%)</td><td align="left">15 260</td><td align="left">13 099 (86%)</td></tr></tbody></table><table-wrap-foot><fn><p>Data are n or n (%).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl1fn1"><label>*</label><p>Excluded after selection because eligibility of members was not confirmed or because the quota for their sex had already been reached.</p></fn></table-wrap-foot></table-wrap></p>
              <p id="para230">Frequencies of STIs varied between cities (<xref rid="tbl2" ref-type="table">Table 2</xref>, <xref rid="tbl3" ref-type="table">Table 3</xref>, <xref rid="tbl4" ref-type="table">Table 4</xref>). In three cities in the Amazon jungle (Tarapoto, Iquitos, and Pucallpa) the prevalence of STIs was notably higher than in other cities, particularly in men (<xref rid="tbl2" ref-type="table">table 2</xref>).<table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p>Prevalences of sexually transmitted infections in men aged 18–29 years by region and city</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="3" align="left"><bold>Serological test results</bold><hr/></th><th colspan="3" align="left"><bold>Nucleic acid amplification testing of urine</bold><hr/></th></tr><tr><th/><th/><th align="left">Syphilis<xref rid="tbl2fn1" ref-type="table-fn">*</xref></th><th align="left">HSV2<xref rid="tbl2fn2" ref-type="table-fn">†</xref></th><th align="left">HIV</th><th align="left"><italic>Neisseria gonorrhoeae</italic></th><th align="left"><italic>Chlamydia trachomatis</italic></th><th align="left"><italic>Trichomonas vaginalis</italic></th></tr></thead><tbody><tr><td colspan="8" align="left">Coastal</td></tr><tr><td/><td align="left">Barranca</td><td align="left">3/213 (1%)</td><td align="left">59 (8%)</td><td align="left">2/213 (1%)</td><td align="left">0/267</td><td align="left">10/267 (4%)</td><td align="left">0/267</td></tr><tr><td/><td align="left">Chimbote</td><td align="left">1/238 (&lt;1%)</td><td align="left">47 (9%)</td><td align="left">0/238</td><td align="left">0/287</td><td align="left">8/287 (3%)</td><td align="left">0/288</td></tr><tr><td/><td align="left">Chincha</td><td align="left">1/231 (&lt;1%)</td><td align="left">30 (28%)</td><td align="left">2/230 (1%)</td><td align="left">1/256 (&lt;1%)</td><td align="left">8/256 (3%)</td><td align="left">0/256</td></tr><tr><td/><td align="left">Ica</td><td align="left">4/232 (2%)</td><td align="left">48 (4%)</td><td align="left">1/232 (&lt;1%)</td><td align="left">0/255</td><td align="left">6/256 (2%)</td><td align="left">1/256 (&lt;1%)</td></tr><tr><td/><td align="left">Ilo</td><td align="left">0/232</td><td align="left">62 (2%)</td><td align="left">0/231</td><td align="left">0/251</td><td align="left">10/251 (4%)</td><td align="left">1/265 (&lt;1%)</td></tr><tr><td/><td align="left">Pisco</td><td align="left">0/259</td><td align="left">52 (8%)</td><td align="left">0/259</td><td align="left">0/265</td><td align="left">10/265 (4%)</td><td align="left">3/281 (1%)</td></tr><tr><td/><td align="left">Piura</td><td align="left">2/234 (&lt;1%)</td><td align="left">51 (1%)</td><td align="left">0/234</td><td align="left">0/278</td><td align="left">3/279 (1%)</td><td align="left">0/280</td></tr><tr><td/><td align="left">Sullana</td><td align="left">0/215</td><td align="left">51 (10%)</td><td align="left">1/215 (1%)</td><td align="left">0/242</td><td align="left">11/243 (5%)</td><td align="left">0/268</td></tr><tr><td/><td align="left">Tacna</td><td align="left">0/243</td><td align="left">36 (5%)</td><td align="left">1/243 (&lt;1%)</td><td align="left">0/244</td><td align="left">10/244 (4%)</td><td align="left">1/264 (&lt;1%)</td></tr><tr><td/><td align="left">Talara</td><td align="left">1/223 (&lt;1%)</td><td align="left">45 (18%)</td><td align="left">1/224 (&lt;1%)</td><td align="left">1/255 (&lt;1%)</td><td align="left">12/255 (5%)</td><td align="left">1/255 (&lt;1%)</td></tr><tr><td/><td align="left">Tumbes</td><td align="left">0/225</td><td align="left">45 (22%)</td><td align="left">1/225 (&lt;1%)</td><td align="left">1/265 (&lt;1%)</td><td align="left">5/265 (2%)</td><td align="left">0/265</td></tr><tr><td colspan="8" align="left">Andean</td></tr><tr><td/><td align="left">Arequipa</td><td align="left">0/213</td><td align="left">26 (9%)</td><td align="left">1/213 (1%)</td><td align="left">0/273</td><td align="left">5/273 (2%)</td><td align="left">0/275</td></tr><tr><td/><td align="left">Ayacucho</td><td align="left">0/259</td><td align="left">51 (8%)</td><td align="left">0/259</td><td align="left">0/270</td><td align="left">11/270 (4%)</td><td align="left">1/272 (&lt;1%)</td></tr><tr><td/><td align="left">Cajamarca</td><td align="left">0/219</td><td align="left">61 (5%)</td><td align="left">0/219</td><td align="left">0/231</td><td align="left">7/231 (3%)</td><td align="left">0/258</td></tr><tr><td/><td align="left">Cerro de Pasco</td><td align="left">0/252</td><td align="left">45 (1%)</td><td align="left">1/252 (&lt;1%)</td><td align="left">0/253</td><td align="left">14/253 (6%)</td><td align="left">0/280</td></tr><tr><td/><td align="left">Cuzco</td><td align="left">1/252 (&lt;1%)</td><td align="left">60 (19%)</td><td align="left">0/252</td><td align="left">0/284</td><td align="left">12/285 (4%)</td><td align="left">2/286 (1%)</td></tr><tr><td/><td align="left">Huancayo</td><td align="left">0/219</td><td align="left">40 (5%)</td><td align="left">0/219</td><td align="left">0/255</td><td align="left">11/255 (4%)</td><td align="left">2/256 (1%)</td></tr><tr><td/><td align="left">Huaraz</td><td align="left">0/225</td><td align="left">42 (7%)</td><td align="left">0/225</td><td align="left">0/265</td><td align="left">13/265 (5%)</td><td align="left">1/265 (&lt;1%)</td></tr><tr><td/><td align="left">Juliaca</td><td align="left">0/261</td><td align="left">50 (0%)</td><td align="left">0/261</td><td align="left">1/244 (&lt;1%)</td><td align="left">12/244 (5%)</td><td align="left">2/289 (1%)</td></tr><tr><td/><td align="left">Puno</td><td align="left">0/265</td><td align="left">60 (&lt;1%)</td><td align="left">2/265 (1%)</td><td align="left">0/247</td><td align="left">14/247 (6%)</td><td align="left">2/300 (1%)</td></tr><tr><td colspan="8" align="left">Amazonian</td></tr><tr><td/><td align="left">Huanuco</td><td align="left">0/210</td><td align="left">59 (9%)</td><td align="left">0/210</td><td align="left">2/234 (1%)</td><td align="left">13/235 (6%)</td><td align="left">4/251 (2%)</td></tr><tr><td/><td align="left">Iquitos</td><td align="left">4/252 (2%)</td><td align="left">51 (38%)</td><td align="left">4/252 (2%)</td><td align="left">0/267</td><td align="left">21/267 (8%)</td><td align="left">1/268 (&lt;1%)</td></tr><tr><td/><td align="left">Pucallpa</td><td align="left">5/260 (2%)</td><td align="left">55 (34%)</td><td align="left">5/260 (%2)</td><td align="left">1/286 (&lt;1%)</td><td align="left">15/286 (5%)</td><td align="left">0/286</td></tr><tr><td/><td align="left">Tarapoto</td><td align="left">6/250 (2%)</td><td align="left">50 (24%)</td><td align="left">0/250</td><td align="left">2/258 (1%)</td><td align="left">8/258 (3%)</td><td align="left">0/267</td></tr><tr><td colspan="2" align="left">Total</td><td align="left">28/5682 (1%)</td><td align="left">1176</td><td align="left">22/5681 (&lt;1%)</td><td align="left">9/6232 (&lt;1%)</td><td align="left">249/6237 (4%)</td><td align="left">22/6498 (&lt;1%)</td></tr><tr><td colspan="2" align="left">Weighted prevalence<xref rid="tbl2fn3" ref-type="table-fn">‡</xref></td><td align="left">0·5%</td><td align="left">13·5%</td><td align="left">0·5%</td><td align="left">0·1%</td><td align="left">4·2%</td><td align="left">0·3%</td></tr></tbody></table><table-wrap-foot><fn><p>Data are number positive/number tested (%) unless otherwise stated. HSV2=herpes simplex virus 2.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fn1"><label>*</label><p>Rapid plasma reagin 1:8 or higher, <italic>Treponema pallidum</italic> particle agglutination positive.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fn2"><label>†</label><p>HSV2 testing was done with a subset of sera available, and thus city prevalences of seropositivity are further weighted accordingly and only denominators are shown.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fn3"><label>‡</label><p>Prevalences weighted by city size.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tbl3"><label>Table 3</label><caption><p>Prevalences of sexually transmitted infections in women aged 18–29 years from the general population by region and city</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="3" align="left"><bold>Serological test results</bold><hr/></th><th colspan="3" align="left"><bold>Nucleic acid amplification testing of urine or vaginal swab</bold><hr/></th></tr><tr><th/><th/><th align="left">Syphilis<xref rid="tbl3fn1" ref-type="table-fn">*</xref></th><th align="left">HSV2<xref rid="tbl3fn2" ref-type="table-fn">†</xref></th><th align="left">HIV</th><th align="left"><italic>Neisseria gonorrhoeae</italic></th><th align="left"><italic>Chlamydia trachomatis</italic></th><th align="left"><italic>Trichomonas vaginalis</italic></th></tr></thead><tbody><tr><td colspan="8" align="left">Coastal</td></tr><tr><td/><td align="left">Barranca</td><td align="left">0/230</td><td align="left">55 (4%)</td><td align="left">0/230</td><td align="left">1/268 (&lt;1%)</td><td align="left">17/267 (6%)</td><td align="left">14/263 (5%)</td></tr><tr><td/><td align="left">Chimbote</td><td align="left">0/237</td><td align="left">52 (16%)</td><td align="left">0/237</td><td align="left">0/271</td><td align="left">12/271 (4%)</td><td align="left">13/270 (5%)</td></tr><tr><td/><td align="left">Chincha</td><td align="left">2/246 (1%)</td><td align="left">63 (22%)</td><td align="left">0/247</td><td align="left">0/263</td><td align="left">17/263 (7%)</td><td align="left">21/262 (8%)</td></tr><tr><td/><td align="left">Ica</td><td align="left">1/243 (&lt;1%)</td><td align="left">49 (19%)</td><td align="left">0/243</td><td align="left">0/262</td><td align="left">8/261 (3%)</td><td align="left">12/262 (5%)</td></tr><tr><td/><td align="left">Ilo</td><td align="left">0/254</td><td align="left">68 (6%)</td><td align="left">0/254</td><td align="left">0/276</td><td align="left">15/276 (5%)</td><td align="left">6/276 (2%)</td></tr><tr><td/><td align="left">Pisco</td><td align="left">0/228</td><td align="left">61 (9%)</td><td align="left">1/228 (&lt;1%)</td><td align="left">0/258</td><td align="left">17/259 (7%)</td><td align="left">24/260 (9%)</td></tr><tr><td/><td align="left">Piura</td><td align="left">0/243</td><td align="left">68 (3%)</td><td align="left">0/243</td><td align="left">0/274</td><td align="left">12/274 (4%)</td><td align="left">12/273 (4%)</td></tr><tr><td/><td align="left">Sullana</td><td align="left">0/218</td><td align="left">64 (14%)</td><td align="left">0/218</td><td align="left">0/249</td><td align="left">9/249 (4%)</td><td align="left">6/254 (2%)</td></tr><tr><td/><td align="left">Tacna</td><td align="left">2/260 (1%)</td><td align="left">51 (14%)</td><td align="left">0/260</td><td align="left">1/283 (&lt;1%)</td><td align="left">22/283 (8%)</td><td align="left">11/283 (4%)</td></tr><tr><td/><td align="left">Talara</td><td align="left">1/242 (&lt;1%)</td><td align="left">67 (10%)</td><td align="left">0/242</td><td align="left">1/263 (&lt;1%)</td><td align="left">15/264 (6%)</td><td align="left">17/261 (7%)</td></tr><tr><td/><td align="left">Tumbes</td><td align="left">0/242</td><td align="left">72 (17%)</td><td align="left">0/242</td><td align="left">1/266 (&lt;1%)</td><td align="left">9/268 (3%)</td><td align="left">6/268 (2%)</td></tr><tr><td colspan="8" align="left">Andean</td></tr><tr><td/><td align="left">Arequipa</td><td align="left">0/205</td><td align="left">48 (9%)</td><td align="left">0/204</td><td align="left">0/296</td><td align="left">12/296 (4%)</td><td align="left">6/298 (2%)</td></tr><tr><td/><td align="left">Ayacucho</td><td align="left">0/253</td><td align="left">60 (9%)</td><td align="left">0/253</td><td align="left">0/265</td><td align="left">19/264 (7%)</td><td align="left">16/262 (6%)</td></tr><tr><td/><td align="left">Cajamarca</td><td align="left">0/219</td><td align="left">51 (2%)</td><td align="left">0/219</td><td align="left">0/250</td><td align="left">15/250 (6%)</td><td align="left">17/254 (7%)</td></tr><tr><td/><td align="left">Cerro de Pasco</td><td align="left">0/270</td><td align="left">64 (12%)</td><td align="left">0/270</td><td align="left">0/282</td><td align="left">14/283 (5%)</td><td align="left">24/285 (8%)</td></tr><tr><td/><td align="left">Cuzco</td><td align="left">2/244 (1%)</td><td align="left">69 (2%)</td><td align="left">0/244</td><td align="left">0/272</td><td align="left">16/272 (6%)</td><td align="left">15/272 (6%)</td></tr><tr><td/><td align="left">Huancayo</td><td align="left">1/244 (&lt;1%)</td><td align="left">49 (9%)</td><td align="left">0/244</td><td align="left">0/272</td><td align="left">24/273 (9%)</td><td align="left">18/272 (7%)</td></tr><tr><td/><td align="left">Huaraz</td><td align="left">0/247</td><td align="left">61 (5%)</td><td align="left">0/247</td><td align="left">1/272 (&lt;1%)</td><td align="left">19/272 (7%)</td><td align="left">18/270 (7%)</td></tr><tr><td/><td align="left">Juliaca</td><td align="left">0/237</td><td align="left">79 (1%)</td><td align="left">0/237</td><td align="left">0/268</td><td align="left">26/268 (10%)</td><td align="left">16/272 (6%)</td></tr><tr><td/><td align="left">Puno</td><td align="left">0/235</td><td align="left">64 (5%)</td><td align="left">0/235</td><td align="left">1/278 (&lt;1%)</td><td align="left">21/278 (8%)</td><td align="left">9/282 (3%)</td></tr><tr><td colspan="8" align="left">Amazonian</td></tr><tr><td/><td align="left">Huanuco</td><td align="left">2/238 (1%)</td><td align="left">47 (8%)</td><td align="left">1/238 (&lt;1%)</td><td align="left">0/263</td><td align="left">16/262 (6%)</td><td align="left">18/263 (7%)</td></tr><tr><td/><td align="left">Iquitos</td><td align="left">4/255 (2%)</td><td align="left">66 (36%)</td><td align="left">0/255</td><td align="left">0/257</td><td align="left">26/258 (10%)</td><td align="left">14/260 (5%)</td></tr><tr><td/><td align="left">Pucallpa</td><td align="left">2/245 (1%)</td><td align="left">67 (33%)</td><td align="left">1/245 (&lt;1%)</td><td align="left">0/258</td><td align="left">29/258 (11%)</td><td align="left">12/260 (5%)</td></tr><tr><td/><td align="left">Tarapoto</td><td align="left">3/264 (1%)</td><td align="left">91 (17%)</td><td align="left">0/264</td><td align="left">1/273 (&lt;1%)</td><td align="left">24/273 (9%)</td><td align="left">11/275 (4%)</td></tr><tr><td colspan="2" align="left">Total</td><td align="left">20/5799 (&lt;1%)</td><td align="left">1486</td><td align="left">3/5799 (&lt;1%)</td><td align="left">7/6439 (&lt;1%)</td><td align="left">414/6442 (6%)</td><td align="left">336/6457 (5%)</td></tr><tr><td colspan="2" align="left">Weighted prevalence<xref rid="tbl3fn3" ref-type="table-fn">‡</xref></td><td align="left">0·4%</td><td align="left">13·6%</td><td align="left">0·1%</td><td align="left">0·1%</td><td align="left">6·5%</td><td align="left">4·9%</td></tr></tbody></table><table-wrap-foot><fn><p>Data are number positive/number tested (%) unless otherwise stated. HSV2=herpes simplex virus 2.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fn1"><label>*</label><p>Rapid plasma reagin 1:8 or higher, <italic>Treponema pallidum</italic> particle agglutination positive.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fn2"><label>†</label><p>HSV2 testing was done with a subset of sera available, and thus city prevalences of seropositivity are further weighted accordingly and only denominators are shown.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fn3"><label>‡</label><p>Prevalences weighted by city size.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tbl4"><label>Table 4</label><caption><p>Prevalences of sexually transmitted infections in female sex workers by region and city</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="3" align="left"><bold>Serological test results</bold><hr/></th><th colspan="3" align="left"><bold>Nucleic acid amplification testing of vaginal swabs</bold><hr/></th></tr><tr><th/><th/><th align="left">Syphilis<xref rid="tbl4fn1" ref-type="table-fn">*</xref></th><th align="left">HSV2<xref rid="tbl4fn2" ref-type="table-fn">†</xref></th><th align="left">HIV</th><th align="left"><italic>Neisseria gonorrhoeae</italic></th><th align="left"><italic>Chlamydia trachomatis</italic></th><th align="left"><italic>Trichomonas vaginalis</italic></th></tr></thead><tbody><tr><td colspan="8" align="left">Coastal</td></tr><tr><td/><td align="left">Barranca</td><td align="left">3/170 (2%)</td><td align="left">14/18 (78%)</td><td align="left">0/168</td><td align="left">4/141 (3%)</td><td align="left">12/141 (9%)</td><td align="left">8/136 (5%)</td></tr><tr><td/><td align="left">Chimbote</td><td align="left">6/197 (3%)</td><td align="left">32/36 (89%)</td><td align="left">2/199 (1%)</td><td align="left">1/200 (1%)</td><td align="left">21/200 (11%)</td><td align="left">14/192 (7%)</td></tr><tr><td/><td align="left">Chincha</td><td align="left">0/196</td><td align="left">5/6 (83%)</td><td align="left">3/199 (2%)</td><td align="left">0/200</td><td align="left">8/200 (4%)</td><td align="left">11/186 (6%)</td></tr><tr><td/><td align="left">Ica</td><td align="left">0/198</td><td align="left">6/9 (67%)</td><td align="left">1/200 (1%)</td><td align="left">0/198</td><td align="left">11/198 (6%)</td><td align="left">9/184 (5%)</td></tr><tr><td/><td align="left">Ilo</td><td align="left">0/200</td><td align="left">5/11 (45%)</td><td align="left">0/200</td><td align="left">2/200 (1%)</td><td align="left">32/200 (16%)</td><td align="left">8/196 (4%)</td></tr><tr><td/><td align="left">Pisco</td><td align="left">3/148 (2%)</td><td align="left">3/7 (43%)</td><td align="left">1/148 (1%)</td><td align="left">0/148</td><td align="left">16/148 (11%)</td><td align="left">17/145 (12%)</td></tr><tr><td/><td align="left">Piura</td><td align="left">2/193 (1%)</td><td align="left">8/11 (73%)</td><td align="left">4/193 (2%)</td><td align="left">3/171 (2%)</td><td align="left">17/171 (10%)</td><td align="left">14/161 (9%)</td></tr><tr><td/><td align="left">Sullana</td><td align="left">2/197 (1%)</td><td align="left">14/27 (52%)</td><td align="left">0/200</td><td align="left">1/197 (1%)</td><td align="left">24/197 (12%)</td><td align="left">22/192 (11%)</td></tr><tr><td/><td align="left">Tacna</td><td align="left">0/172</td><td align="left">6/10 (60%)</td><td align="left">1/205 (1%)</td><td align="left">0/196</td><td align="left">39/196 (20%)</td><td align="left">15/193 (8%)</td></tr><tr><td/><td align="left">Talara</td><td align="left">0/152</td><td align="left">5/12 (42%)</td><td align="left">2/143 (1%)</td><td align="left">0/156</td><td align="left">21/156 (13%)</td><td align="left">12/155 (8%)</td></tr><tr><td/><td align="left">Tumbes</td><td align="left">2/72 (3%)</td><td align="left">10/12 (83%)</td><td align="left">2/74 (3%)</td><td align="left">1/57 (2%)</td><td align="left">6/57 (11%)</td><td align="left">3/53 (6%)</td></tr><tr><td colspan="8" align="left">Andean</td></tr><tr><td/><td align="left">Arequipa</td><td align="left">1/198 (1%)</td><td align="left">4/10 (40%)</td><td align="left">1/201 (1%)</td><td align="left">1/188 (1%)</td><td align="left">42/188 (22%)</td><td align="left">21/194 (11%)</td></tr><tr><td/><td align="left">Ayacucho</td><td align="left">2/143 (1%)</td><td align="left">9/15 (60%)</td><td align="left">1/147 (1%)</td><td align="left">1/147 (1%)</td><td align="left">18/147 (12%)</td><td align="left">8/143 (6%)</td></tr><tr><td/><td align="left">Cajamarca</td><td align="left">2/177 (1%)</td><td align="left">9/12 (75%)</td><td align="left">0/184</td><td align="left">0/196</td><td align="left">32/196 (16%)</td><td align="left">21/184 (11%)</td></tr><tr><td/><td align="left">Cerro de Pasco</td><td align="left">1/194 (1%)</td><td align="left">3/17 (18%)</td><td align="left">0/199</td><td align="left">0/200</td><td align="left">40/200 (20%)</td><td align="left">24/196 (12%)</td></tr><tr><td/><td align="left">Cusco</td><td align="left">1/208 (1%)</td><td align="left">10/17 (59%)</td><td align="left">0/208</td><td align="left">0/200</td><td align="left">21/200 (11%)</td><td align="left">18/194 (9%)</td></tr><tr><td/><td align="left">Huancayo</td><td align="left">1/194 (1%)</td><td align="left">5/10 (50%)</td><td align="left">0/196</td><td align="left">2/185 (1%)</td><td align="left">24/185 (13%)</td><td align="left">7/181 (4%)</td></tr><tr><td/><td align="left">Huaraz</td><td align="left">1/143 (1%)</td><td align="left">8/11 (73%)</td><td align="left">1/140 (1%)</td><td align="left">1/138 (1%)</td><td align="left">22/138 (16%)</td><td align="left">12/137 (9%)</td></tr><tr><td/><td align="left">Juliaca</td><td align="left">1/194 (1%)</td><td align="left">1/11 (9%)</td><td align="left">0/197</td><td align="left">2/177 (1%)</td><td align="left">29/177 (16%)</td><td align="left">8/171 (5%)</td></tr><tr><td/><td align="left">Puno</td><td align="left">0/200</td><td align="left">4/14 (29%)</td><td align="left">0/201</td><td align="left">3/183 (2%)</td><td align="left">32/183 (17%)</td><td align="left">13/182 (7%)</td></tr><tr><td colspan="8" align="left">Amazonian</td></tr><tr><td/><td align="left">Huanuco</td><td align="left">7/203 (3%)</td><td align="left">16/21 (76%)</td><td align="left">1/202 (1%)</td><td align="left">7/204 (3%)</td><td align="left">46/204 (23%)</td><td align="left">40/194 (21%)</td></tr><tr><td/><td align="left">Iquitos</td><td align="left">9/197 (5%)</td><td align="left">26/26 (100%)</td><td align="left">3/200 (2%)</td><td align="left">20/198 (10%)</td><td align="left">36/198 (18%)</td><td align="left">17/175 (10%)</td></tr><tr><td/><td align="left">Pucallpa</td><td align="left">7/195 (4%)</td><td align="left">31/32 (97%)</td><td align="left">3/200 (2%)</td><td align="left">8/181 (4%)</td><td align="left">36/181 (20%)</td><td align="left">17/171 (10%)</td></tr><tr><td/><td align="left">Tarapoto</td><td align="left">5/173 (3%)</td><td align="left">23/26 (89%)</td><td align="left">3/159 (2%)</td><td align="left">12/202 (6%)</td><td align="left">48/202 (24%)</td><td align="left">24/190 (13%)</td></tr><tr><td colspan="2" align="left">Total</td><td align="left">56/4314 (1%)</td><td align="left">257/381 (67%)</td><td align="left">29/4363 (1%)</td><td align="left">69/4263 (2%)</td><td align="left">633/4263 (15%)</td><td align="left">363/4105 (9%)</td></tr><tr><td colspan="2" align="left">Age-adjusted prevalence<xref rid="tbl4fn3" ref-type="table-fn">‡</xref></td><td align="left">0·8%</td><td align="left">60·6%</td><td align="left">0·5%</td><td align="left">1·6%</td><td align="left">16·4%</td><td align="left">7·9%</td></tr></tbody></table><table-wrap-foot><fn><p>Data are number positive/number tested (%) unless otherwise stated. HSV2=herpes simplex virus 2.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl4fn1"><label>*</label><p>Rapid plasma reagin 1:8 or higher, <italic>Treponema pallidum</italic> particle agglutination positive.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl4fn2"><label>†</label><p>HSV2 testing done with a self-weighted subset of sera available.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl4fn3"><label>‡</label><p>Restricted to 18–29-year-old female sex workers, and standardised to the age composition of women in the general populations survey (age compositions in the two groups were very similar).</p></fn></table-wrap-foot></table-wrap></p>
              <p id="para240">6069 men (81·1%) and 5623 women (72·3%) reported previous sexual intercourse. Prevalences were generally lower in participants denying sexual experience than in those reporting previous sexual intercourse (<xref rid="tbl5" ref-type="table">table 5</xref>). Only four (0·3%) of 1530 sera specimens from individuals from the general population were positive for human T-lymphotropic virus 1 (two men, two women), and none were positive for human T-lymphotropic virus 2.<table-wrap position="float" id="tbl5"><label>Table 5</label><caption><p>Prevalences of infections</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="2" align="left"><bold>Men</bold><hr/></th><th colspan="2" align="left"><bold>Women</bold><hr/></th></tr><tr><th/><th align="left">Sexually experienced (n=6069)</th><th align="left">Not sexually experienced (n=1417)</th><th align="left">Sexually experienced (n=5623)</th><th align="left">Not sexually experienced (n=2152)</th></tr></thead><tbody><tr><td align="left">Herpes simplex virus 2<xref rid="tbl5fn1" ref-type="table-fn">*</xref></td><td align="left">14·6%</td><td align="left">6·6%</td><td align="left">17·4%</td><td align="left">1·3%</td></tr><tr><td align="left">HIV</td><td align="left">0·4%</td><td align="left">0·2%</td><td align="left">0·1%</td><td align="left">0</td></tr><tr><td align="left">Syphilis<xref rid="tbl5fn2" ref-type="table-fn">†</xref></td><td align="left">0·5%</td><td align="left">0·5%</td><td align="left">0·4%</td><td align="left">0·2%</td></tr><tr><td align="left"><italic>Chlamydia trachomatis</italic></td><td align="left">4·6%</td><td align="left">1·2%</td><td align="left">7·8%</td><td align="left">2·0%</td></tr><tr><td align="left"><italic>Trichomonas vaginalis</italic></td><td align="left">0·4%</td><td align="left">0</td><td align="left">5·8%</td><td align="left">3·3%</td></tr><tr><td align="left"><italic>Neisseria gonorrhoeae</italic></td><td align="left">0·1%</td><td align="left">0·2%</td><td align="left">0·1%</td><td align="left">0·1%</td></tr></tbody></table><table-wrap-foot><fn id="tbl5fn1"><label>*</label><p>Weighted values.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl5fn2"><label>†</label><p>Rapid plasma reagin 1:8 or higher, <italic>Treponema pallidum</italic> particle agglutination positive.</p></fn></table-wrap-foot></table-wrap></p>
              <p id="para250">Of sexually experienced men from the general population, 460 (7·6%) reported sex with another man and 447 (7·4%) unprotected sex with an FSW within the past year. Of 5607 sexually experienced women from the general population for whom responses to the three relevant questions were available, 233 (4·2%) reported receiving money in exchange for sex from any of their past three sex partners. In most risk groups of men and women from the general population and in FSWs, HSV2 seropositivity had the highest prevalence, then <italic>C trachomatis</italic> infection, and then <italic>T vaginalis</italic> infection in women (<xref rid="fig1" ref-type="fig">figure</xref>, <xref rid="tbl6" ref-type="table">table 6</xref>). Prevalences of the various STIs clearly differ by risk group (<xref rid="tbl6" ref-type="table">table 6</xref>).<fig id="fig1"><label>Figure</label><caption><p>Prevalences of sexually transmitted infections by subgroups of men and women aged 18–29 years from the general population, in all FSWs, and in age-adjusted FSWs</p><p>Age-adjusted data for FSWs aged 18–29 years were weighted for comparison with women from the general population. FSW=female sex worker. HSV2=herpes simplex virus 2. *HSV2 testing was done with a subset of sera available, and thus city prevalences of seropositivity are further weighted accordingly. †Rapid plasma reagin 1:8 or higher, <italic>Treponema pallidum</italic> particle agglutination positive.</p></caption><graphic xlink:href="gr1"/></fig><table-wrap position="float" id="tbl6"><label>Table 6</label><caption><p>Prevalences of sexually transmitted infections by risk category</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="4" align="left"><bold>Men</bold><hr/></th><th colspan="5" align="left"><bold>Women</bold><hr/></th></tr><tr><th/><th align="left">Without sexual experience (n=1129)</th><th align="left">Had sex with men in past year (n=432)</th><th align="left">Had unprotected sex with FSW in past year (n=284)<xref rid="tbl6fn1" ref-type="table-fn">*</xref></th><th align="left">Others with sexual experience (n=4689)</th><th align="left">From general population without sexual experience (n=1512)</th><th align="left">From general population and paid for sex by any of last three partners (n=219)</th><th align="left">Others from general population with sexual experience (n=4792)</th><th align="left">All FSWs (n=4463)</th><th align="left">Age-adjusted sample of FSWs (n=4463)<xref rid="tbl6fn2" ref-type="table-fn">†</xref></th></tr></thead><tbody><tr><td align="left"><italic>Neisseria gonorrhoeae</italic></td><td align="left">0·19%</td><td align="left">0·73%</td><td align="left">0·73%</td><td align="left">0·04%</td><td align="left">0·07%</td><td align="left">0·00%</td><td align="left">0·13%</td><td align="left">1·62%</td><td align="left">1·64%</td></tr><tr><td align="left">HIV</td><td align="left">0·22%</td><td align="left">2·52%</td><td align="left">1·13%</td><td align="left">0·17%</td><td align="left">0·00%</td><td align="left">1·04%</td><td align="left">0·02%</td><td align="left">0·66%</td><td align="left">0·52%</td></tr><tr><td align="left">Syphilis<xref rid="tbl6fn3" ref-type="table-fn">‡</xref></td><td align="left">0·54%</td><td align="left">3·02%</td><td align="left">0·75%</td><td align="left">0·22%</td><td align="left">0·16%</td><td align="left">1·55%</td><td align="left">0·35%</td><td align="left">1·30%</td><td align="left">0·78%</td></tr><tr><td align="left"><italic>Trichomonas vaginalis</italic></td><td align="left">0</td><td align="left">0·00%</td><td align="left">0·36%</td><td align="left">0·45%</td><td align="left">3·29%</td><td align="left">7·83%</td><td align="left">5·70%</td><td align="left">8·84%</td><td align="left">7·87%</td></tr><tr><td align="left"><italic>Chlamydia trachomatis</italic></td><td align="left">1·21%</td><td align="left">6·02%</td><td align="left">3·64%</td><td align="left">4·49%</td><td align="left">1·89%</td><td align="left">10·23%</td><td align="left">7·68%</td><td align="left">14·85%</td><td align="left">16·41%</td></tr><tr><td align="left">HSV2<xref rid="tbl6fn4" ref-type="table-fn">§</xref></td><td align="left">6·63%</td><td align="left">44·66%</td><td align="left">17·47%</td><td align="left">10·00%</td><td align="left">1·29%</td><td align="left">17·60%</td><td align="left">17·42%</td><td align="left">67·45%</td><td align="left">60·58%</td></tr></tbody></table><table-wrap-foot><fn><p>Patients in each risk category are those who provided questionnaire data and had at least one laboratory test result. FSW=female sex worker. HSV2=herpes simplex virus 2.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl6fn1"><label>*</label><p>Excludes individuals who also had sex with men.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl6fn2"><label>†</label><p>18–29-year-old FSWs, standardised to the age composition of women in the general-population survey.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl6fn3"><label>‡</label><p>Rapid plasma reagin 1:8 or higher, <italic>Treponema pallidum</italic> particle agglutination positive.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl6fn4"><label>§</label><p>HSV2 seroprevalence is weighted by city size and sampling probability.</p></fn></table-wrap-foot></table-wrap></p>
              <p id="para260">Additionally, STI prevalence ratios showed differences between risk subgroups (<xref rid="sec1" ref-type="sec">appendix</xref>). Compared with sexually experienced women from the general population not receiving money for sex, FSWs had significantly higher age-adjusted prevalences of <italic>N gonorrhoeae</italic> (prevalence ratio 12·31, p=0·004), HSV2 (3·12, p&lt;0·001), syphilis (3·04, p&lt;0·001), <italic>C trachomatis</italic> (2·09, p&lt;0·001), and <italic>T vaginalis</italic> (1·56, p&lt;0·001; <xref rid="sec1" ref-type="sec">appendix</xref>). Furthermore, prevalence of syphilis in women from the general population receiving money for sex from any of the past three partners was significantly higher (4·77, p=0·016) and prevalence of HIV was also increased (40·17, p=0·010; <xref rid="sec1" ref-type="sec">appendix</xref>) compared with sexually experienced women who did not receive money for sex. Women denying sexual experience had lower prevalences of all STIs than did sexually experienced women, although the difference was significant only for infection with <italic>C trachomatis</italic> (0·19, p&lt;0·001), HSV2 (0·25, p=0·007), and <italic>T vaginalis</italic> (0·57, p&lt;0·001; <xref rid="sec1" ref-type="sec">appendix</xref>).</p>
              <p id="para270">Compared with sexually experienced men reporting neither sex with men nor unprotected sex with FSWs during the past year, men reporting sex with men had significantly higher prevalences of HIV, syphilis, <italic>N gonorrhoeae</italic>, and HSV2 (<xref rid="sec1" ref-type="sec">appendix</xref>). Exclusively heterosexual men reporting unprotected sex with FSWs during the past year had significantly higher prevalences of <italic>N gonorrhoeae</italic> and HIV, and men denying sexual experience had significantly lower prevalences of <italic>C trachomatis</italic> and <italic>T vaginalis</italic> infection than did sexually experienced individuals not reporting unprotected sex with FSWs (<xref rid="sec1" ref-type="sec">appendix</xref>). In men and women from the general population denying sexual experience, HSV2 seropositivity, <italic>C trachomatis</italic>, and (in women only) <italic>T vaginalis</italic>, were nonetheless occasionally reported (<xref rid="sec1" ref-type="sec">appendix</xref>).</p>
              <p id="para280">Of 5405 sexually experienced men from the general population for whom laboratory results were available, 432 (8·0%) reported sex with men and 284 (5·3%) exclusively heterosexual men reported unprotected sex with FSWs in the past year. These men accounted for 65·0% of infections with HIV, 60·9% of cases of syphilis, 71·5% of infections with <italic>N gonorrhoeae</italic>, and 41·4% of infections with HSV2, but only 14·8% of <italic>C trachomatis</italic> and 4·5% of <italic>T vaginalis</italic> infections. Of 5011 sexually experienced women from the general population for whom laboratory results were available, 219 (4·4%) reported sex for money with any of their past three partners. These women accounted for 66·7% of infections with HIV and 16·7% of cases of syphilis, but only 0·1% of <italic>N gonorrhoeae,</italic> 5·1% of HSV2, 5·7% of <italic>C trachomatis</italic>, and 5·9% of <italic>T vaginalis</italic> infections.</p>
            </sec>
            <sec id="cesec80">
              <title>Discussion</title>
              <p id="para290">We have shown that, even in household samples, women reporting receiving money for sex accounted for most infections with HIV in women from the general population. Men who have sex with men and heterosexual men reporting unprotected sex with FSWs accounted for most HIV and <italic>N gonorrhoeae</italic> infections and cases of syphilis in men from the general population. Differences between the sexes in the general population for syphilis and HIV infection were largely a result of concentration of these diseases in men who have sex with men. Survey participation rates were high; detailed sociobehavioral and STI test data allowed us to definitively show that STI prevalences differ greatly between risk groups. These data, when coupled with large numbers of sexual partners for individuals in high-risk groups, clearly suggest that targeted, strong preventive interventions are needed in the general population and for FSWs. The results provided baseline data for an urban community-randomised trial of STI prevention—the Peru PREVEN study.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref></p>
              <p id="para300">Investigators of Latin American studies in 1991 and 1992 (of 18–30-year-old patients undergoing routine health examinations in Lima, Peru, and 17–30-year-old sex workers in Mexico City, Mexico) recorded HSV2 seroprevalences<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> that are similar to the values reported by us for young adults and FSWs in Peru. Infections with <italic>N gonorrhoeae</italic> and HIV and cases of syphilis were absent or nearly absent in many Peruvian cities, even in FSWs. Peru's approach to control of these STIs, at least in heterosexual individuals, warrant continuation. The high prevalences of <italic>C trachomatis</italic> and <italic>T vaginalis</italic> call for innovative improvements in control of both infections. Even higher prevalences of syphilis, <italic>C trachomatis</italic>, and (for women) of <italic>T vaginalis</italic> than in our study have been reported in samples of socially marginalised men (eg, gang members) and women in three coastal cities of Peru,<xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib16" ref-type="bibr">16</xref> suggesting that preventive interventions for such populations will also be important, although challenging to implement. Reasons for substantially higher rates of STIs in certain cities—particularly Amazonian cities—will be further explored in community-level analyses.</p>
              <p id="para310">The PREVEN surveys extend comprehensive surveillance results from US studies (<xref rid="box1" ref-type="boxed-text">panel</xref>) to Latin America. PREVEN complements the US studies because of the high rates of participation and completion of questionnaires; the assessment of prevalence not only by age, sex, and (in men) sexual orientation, but also by region and history of sex for money; and the surveying of FSWs.<boxed-text id="box1"><label>Panel</label><caption><title>Research in context</title></caption><p id="para10"><bold>Systematic review</bold></p><p id="para20">We used PubMed to search Medline with the term “population based survey prevalence” in combination with each pathogen we studied. We identified reports of surveys temporally overlapping with the period 2000–03 published in English in which participants were specifically tested for several sexually transmitted infections (STIs), including the National Health and Nutrition Exam Survey (NHANES) and National Longitudinal Study of Adolescent Health (Add Health) in the USA. We did not include several other population-based surveys that focused on only <italic>Chlamydia trachomatis</italic>, HIV infection, or history of STIs. Population-based data for STIs other than <italic>C trachomatis</italic> or HIV infections were scarce, except in the USA and Peru. During the time of our surveys, NHANES and Add Health examined prevalences of several STIs in young adults in the USA. In 5767 individuals aged 18–49 years in the 2001–04 NHANES, syphilis seroprevalence (rapid plasma reagin titre 1:8 or more) was 0·08%.<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> The 1999–2004 NHANES used immunodot assays for herpes simplex virus 2 (HSV2) in 2412 adults aged 20–29 years, and showed that prevalence of HSV2 seropositivity in men was 5·6% and in women 15·6%.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> In the 2001–04 NHANES, prevalence of <italic>Trichomonas vaginalis</italic> in urine by PCR was 2·2% in 20–29-year-old women.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> In the 1999–2002 NHANES,<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> ligase chain reaction tests of urine showed that prevalence of <italic>Neisseria gonorrhoeae</italic> was 0·21% in men and women combined, and prevalence of <italic>C trachomatis</italic> was 1·9% in women and 3·2% in men. Similarly, in wave 3 (2001–02) of Add Health—a sample of 14 322 18–26-year-old adults—prevalence of <italic>C trachomatis</italic> by ligase chain reaction was 4·7% in women and 3·1% in men, and prevalence of <italic>N gonorrhoeae</italic> was 0·42% in women and 0·44% in men.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> Prevalence of <italic>T vaginalis</italic> was 2·8% in women and 1·7% in men.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> HIV prevalence measured with oral mucosal transudate assay was 0·1% in men and 0·09% in women, but only 0·02% in individuals not classified as non-Hispanic black.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> A national stratified probability sample of 3426 individuals aged 20–64 years surveyed in 1999–2000 in China with urine ligase chain reaction<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> established that prevalence of <italic>N gonorrhoeae</italic> was 0·08% in women and 0·02% in men. Prevalence of <italic>C trachomatis</italic> was 2·7% in women and 3·3% in men aged 20–34 years. The Natsal 2000 stratified probability survey in Britain (1999–2001) showed that prevalence of <italic>C trachomatis</italic> measured with urine ligase chain reaction was 3·0% in men 25–34-years-old, and 3·0% in women aged 18–24 years.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> Finally, in 2011, WHO estimated prevalences of STIs with 2002–05 data from South and Central America and the Caribbean for 15–49-year-old women and men.<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref></p><p id="para30"><bold>Interpretation</bold></p><p id="para40">We have reported prevalences of STIs that are generally higher than are those that have been recorded previously. However, the new prevalence estimates reported by WHO are generally similar to what we have reported, although frequency of <italic>T vaginalis</italic> and <italic>N gonorrhoeae</italic> infection was lower in our study than the WHO estimates. Our results for subgroups and those from NHANES and Add Health, showing that a small number of high risk groups account for most cases of STIs, could guide targeting of interventions in the future in similar settings. Additionally, our finding that STIs are more common in Amazonian cities indicates that preventive interventions for individuals who live in these regions are important.</p></boxed-text></p>
              <p id="para320">We excluded Lima, which has had increased rates of HIV infection in men who have sex with men<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> and post-partum women;<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> we also excluded rural populations. PREVEN study leaders have previously surveyed STIs in rural women throughout Peru.<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> Our general-population survey cannot be generalised to populations that are younger or older than ours was, to non-household-based populations, or to individuals living in a city for less than 6 months. Exclusion of non-household populations has been argued to have little effect on national HIV seroprevalence estimates for household surveys;<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> household-based HIV prevalence surveys could provide useful incidence estimates.<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref></p>
              <p id="para330">Overall, national surveys can inform national health care and prevention policies, and could motivate similar surveillance elsewhere. Global burden of disease analyses rely on such data. Definition of risk factors in such surveys, and concurrent surveys from high-risk populations, will be increasingly important for targeting of interventions for communicable diseases.</p>
            </sec>
          </body>
          <back>
            <ref-list id="bibl10">
              <title>References</title>
              <ref id="bib1">
                <label>1</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baiden</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Hodgson</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Binka</surname>
                      <given-names>FN</given-names>
                    </name>
                  </person-group>
                  <article-title>Demographic surveillance sites and emerging challenges in international health</article-title>
                  <source>Bull World Health Organ</source>
                  <volume>84</volume>
                  <year>2006</year>
                  <fpage>163</fpage>
                  <pub-id pub-id-type="pmid">16583067</pub-id>
                </element-citation>
              </ref>
              <ref id="bib2">
                <label>2</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ghys</surname>
                      <given-names>PD</given-names>
                    </name>
                    <name>
                      <surname>Kufa</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>George</surname>
                      <given-names>MV</given-names>
                    </name>
                  </person-group>
                  <article-title>Measuring trends in prevalence and incidence of HIV infection in countries with generalised epidemics</article-title>
                  <source>Sex Transm Infect</source>
                  <volume>82</volume>
                  <issue>suppl 1</issue>
                  <year>2006</year>
                  <fpage>i52</fpage>
                  <lpage>i56</lpage>
                  <pub-id pub-id-type="pmid">16581761</pub-id>
                </element-citation>
              </ref>
              <ref id="bib3">
                <label>3</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Allsworth</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Ratner</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Peipert</surname>
                      <given-names>JF</given-names>
                    </name>
                  </person-group>
                  <article-title>Trichomoniasis and other sexually transmitted infections: results from the 2001–2004 National Health and Nutrition Examination Surveys</article-title>
                  <source>Sex Transm Dis</source>
                  <volume>36</volume>
                  <year>2009</year>
                  <fpage>738</fpage>
                  <lpage>744</lpage>
                  <pub-id pub-id-type="pmid">19734826</pub-id>
                </element-citation>
              </ref>
              <ref id="bib4">
                <label>4</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McCadden</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Fenton</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>McManus</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title><italic>Chlamydia trachomatis</italic> testing in the second British national survey of sexual attitudes and lifestyles: respondent uptake and treatment outcomes</article-title>
                  <source>Sex Transm Dis</source>
                  <volume>32</volume>
                  <year>2005</year>
                  <fpage>387</fpage>
                  <lpage>394</lpage>
                  <pub-id pub-id-type="pmid">15912087</pub-id>
                </element-citation>
              </ref>
              <ref id="bib5">
                <label>5</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Montana</surname>
                      <given-names>LS</given-names>
                    </name>
                    <name>
                      <surname>Mishra</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Hong</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of HIV prevalence estimates from antenatal care surveillance and population-based surveys in sub-Saharan Africa</article-title>
                  <source>Sex Transm Infect</source>
                  <volume>84</volume>
                  <issue>suppl 1</issue>
                  <year>2008</year>
                  <fpage>i78</fpage>
                  <lpage>i84</lpage>
                  <pub-id pub-id-type="pmid">18647871</pub-id>
                </element-citation>
              </ref>
              <ref id="bib6">
                <label>6</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>ACSF investigators</collab>
                  </person-group>
                  <article-title>AIDS and sexual behaviour in France</article-title>
                  <source>Nature</source>
                  <volume>360</volume>
                  <year>1992</year>
                  <fpage>407</fpage>
                  <lpage>409</lpage>
                  <pub-id pub-id-type="pmid">1448162</pub-id>
                </element-citation>
              </ref>
              <ref id="bib7">
                <label>7</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mertz</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>McQuillan</surname>
                      <given-names>GM</given-names>
                    </name>
                    <name>
                      <surname>Levine</surname>
                      <given-names>WC</given-names>
                    </name>
                  </person-group>
                  <article-title>A pilot study of the prevalence of chlamydial infection in a national household survey</article-title>
                  <source>Sex Transm Dis</source>
                  <volume>25</volume>
                  <year>1998</year>
                  <fpage>225</fpage>
                  <lpage>228</lpage>
                  <pub-id pub-id-type="pmid">9587171</pub-id>
                </element-citation>
              </ref>
              <ref id="bib8">
                <label>8</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wawer</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Gray</surname>
                      <given-names>RH</given-names>
                    </name>
                    <name>
                      <surname>Sewankambo</surname>
                      <given-names>NK</given-names>
                    </name>
                  </person-group>
                  <article-title>A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda</article-title>
                  <source>AIDS</source>
                  <volume>12</volume>
                  <year>1998</year>
                  <fpage>1211</fpage>
                  <lpage>1225</lpage>
                  <pub-id pub-id-type="pmid">9677171</pub-id>
                </element-citation>
              </ref>
              <ref id="bib9">
                <label>9</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gregson</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Nyamukapa</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Garnett</surname>
                      <given-names>GP</given-names>
                    </name>
                  </person-group>
                  <article-title>Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe</article-title>
                  <source>Lancet</source>
                  <volume>359</volume>
                  <year>2002</year>
                  <fpage>1896</fpage>
                  <lpage>1903</lpage>
                  <pub-id pub-id-type="pmid">12057552</pub-id>
                </element-citation>
              </ref>
              <ref id="bib10">
                <label>10</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dubuis</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Gorgievski-Hrisoho</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Germann</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Matter</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of 2-SP transport medium for detection of <italic>Chlamydia trachomatis</italic> and <italic>Neisseria gonorrhoeae</italic> by two automated amplification systems and culture for chlamydia</article-title>
                  <source>J Clin Pathol</source>
                  <volume>50</volume>
                  <year>1997</year>
                  <fpage>947</fpage>
                  <lpage>950</lpage>
                  <pub-id pub-id-type="pmid">9462247</pub-id>
                </element-citation>
              </ref>
              <ref id="bib11">
                <label>11</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spielberg</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Branson</surname>
                      <given-names>BM</given-names>
                    </name>
                    <name>
                      <surname>Goldbaum</surname>
                      <given-names>GM</given-names>
                    </name>
                  </person-group>
                  <article-title>Choosing HIV counseling and testing strategies for outreach settings: a randomized trial</article-title>
                  <source>J Acquir Immune Defic Syndr</source>
                  <volume>38</volume>
                  <year>2005</year>
                  <fpage>348</fpage>
                  <lpage>355</lpage>
                  <pub-id pub-id-type="pmid">15735456</pub-id>
                </element-citation>
              </ref>
              <ref id="bib12">
                <label>12</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>García</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Holmes</surname>
                      <given-names>KK</given-names>
                    </name>
                    <name>
                      <surname>Cárcamo</surname>
                      <given-names>CP</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial</article-title>
                  <source>Lancet</source>
                  <volume>379</volume>
                  <year>2012</year>
                  <fpage>1120</fpage>
                  <lpage>1128</lpage>
                  <pub-id pub-id-type="pmid">22341824</pub-id>
                </element-citation>
              </ref>
              <ref id="bib13">
                <label>13</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Robinson</surname>
                      <given-names>NJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review</article-title>
                  <source>J Infect Dis</source>
                  <volume>186</volume>
                  <issue>suppl 1</issue>
                  <year>2002</year>
                  <fpage>S3</fpage>
                  <lpage>28</lpage>
                  <pub-id pub-id-type="pmid">12353183</pub-id>
                </element-citation>
              </ref>
              <ref id="bib14">
                <label>14</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>León</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Konda</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Klausner</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>FR</given-names>
                    </name>
                    <name>
                      <surname>Cáceres</surname>
                      <given-names>CF</given-names>
                    </name>
                    <name>
                      <surname>Coates</surname>
                      <given-names>TJ</given-names>
                    </name>
                  </person-group>
                  <article-title><italic>Chlamydia trachomatis</italic> infection and associated risk factors in a low-income marginalized urban population in coastal Peru</article-title>
                  <source>Rev Panam Salud Publica</source>
                  <volume>26</volume>
                  <year>2009</year>
                  <fpage>39</fpage>
                  <lpage>45</lpage>
                  <pub-id pub-id-type="pmid">19814880</pub-id>
                </element-citation>
              </ref>
              <ref id="bib15">
                <label>15</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leon</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Konda</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>KT</given-names>
                    </name>
                  </person-group>
                  <article-title><italic>Trichomonas vaginalis</italic> infection and associated risk factors in a socially-marginalized female population in coastal Peru</article-title>
                  <source>Infect Dis Obstet Gynecol</source>
                  <volume>2009</volume>
                  <year>2009</year>
                  <fpage>752437</fpage>
                  <pub-id pub-id-type="pmid">19584943</pub-id>
                </element-citation>
              </ref>
              <ref id="bib16">
                <label>16</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Snowden</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Konda</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Leon</surname>
                      <given-names>SR</given-names>
                    </name>
                  </person-group>
                  <article-title>Recent syphilis infection prevalence and risk factors among male low-income populations in coastal Peruvian cities</article-title>
                  <source>Sex Transm Dis</source>
                  <volume>37</volume>
                  <year>2010</year>
                  <fpage>75</fpage>
                  <lpage>80</lpage>
                  <pub-id pub-id-type="pmid">19940809</pub-id>
                </element-citation>
              </ref>
              <ref id="bib17">
                <label>17</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gottlieb</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Pope</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Sternberg</surname>
                      <given-names>MR</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence of syphilis seroreactivity in the United States: data from the National Health and Nutrition Examination Surveys (NHANES) 2001–2004</article-title>
                  <source>Sex Transm Dis</source>
                  <volume>35</volume>
                  <year>2008</year>
                  <fpage>507</fpage>
                  <lpage>511</lpage>
                  <pub-id pub-id-type="pmid">18356772</pub-id>
                </element-citation>
              </ref>
              <ref id="bib18">
                <label>18</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xu</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Sternberg</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Kottiri</surname>
                      <given-names>BJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States</article-title>
                  <source>JAMA</source>
                  <volume>296</volume>
                  <year>2006</year>
                  <fpage>964</fpage>
                  <lpage>973</lpage>
                  <pub-id pub-id-type="pmid">16926356</pub-id>
                </element-citation>
              </ref>
              <ref id="bib19">
                <label>19</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Datta</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Sternberg</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>RE</given-names>
                    </name>
                  </person-group>
                  <article-title>Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002</article-title>
                  <source>Ann Intern Med</source>
                  <volume>147</volume>
                  <year>2007</year>
                  <fpage>89</fpage>
                  <lpage>96</lpage>
                  <pub-id pub-id-type="pmid">17638719</pub-id>
                </element-citation>
              </ref>
              <ref id="bib20">
                <label>20</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miller</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Ford</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Morris</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence of chlamydial and gonococcal infections among young adults in the United States</article-title>
                  <source>JAMA</source>
                  <volume>291</volume>
                  <year>2004</year>
                  <fpage>2229</fpage>
                  <lpage>2236</lpage>
                  <pub-id pub-id-type="pmid">15138245</pub-id>
                </element-citation>
              </ref>
              <ref id="bib21">
                <label>21</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miller</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Swygard</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Hobbs</surname>
                      <given-names>MM</given-names>
                    </name>
                  </person-group>
                  <article-title>The prevalence of trichomoniasis in young adults in the United States</article-title>
                  <source>Sex Transm Dis</source>
                  <volume>32</volume>
                  <year>2005</year>
                  <fpage>593</fpage>
                  <lpage>598</lpage>
                  <pub-id pub-id-type="pmid">16205299</pub-id>
                </element-citation>
              </ref>
              <ref id="bib22">
                <label>22</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Morris</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Handcock</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>WC</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence of HIV infection among young adults in the United States: results from the Add Health study</article-title>
                  <source>Am J Public Health</source>
                  <volume>96</volume>
                  <year>2006</year>
                  <fpage>1091</fpage>
                  <lpage>1097</lpage>
                  <pub-id pub-id-type="pmid">16670236</pub-id>
                </element-citation>
              </ref>
              <ref id="bib23">
                <label>23</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parish</surname>
                      <given-names>WL</given-names>
                    </name>
                    <name>
                      <surname>Laumann</surname>
                      <given-names>EO</given-names>
                    </name>
                    <name>
                      <surname>Cohen</surname>
                      <given-names>MS</given-names>
                    </name>
                  </person-group>
                  <article-title>Population-based study of chlamydial infection in China: a hidden epidemic</article-title>
                  <source>JAMA</source>
                  <volume>289</volume>
                  <year>2003</year>
                  <fpage>1265</fpage>
                  <lpage>1273</lpage>
                  <pub-id pub-id-type="pmid">12633188</pub-id>
                </element-citation>
              </ref>
              <ref id="bib24">
                <label>24</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fenton</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Korovessis</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>AM</given-names>
                    </name>
                  </person-group>
                  <article-title>Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital <italic>Chlamydia trachomatis</italic> infection</article-title>
                  <source>Lancet</source>
                  <volume>358</volume>
                  <year>2001</year>
                  <fpage>1851</fpage>
                  <lpage>1854</lpage>
                  <pub-id pub-id-type="pmid">11741624</pub-id>
                </element-citation>
              </ref>
              <ref id="bib25">
                <label>25</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>WHO</collab>
                  </person-group>
                  <source>Prevalence and incidence of selected sexually transmitted infections, <italic>Chlamydia trachomatis</italic>, <italic>Neisseria gonorrhoeae</italic>, syphilis and <italic>Trichomonas vaginalis</italic>: methods and results used by WHO to generate 2005 estimates</source>
                  <year>2011</year>
                  <publisher-name>World Health Organization</publisher-name>
                  <publisher-loc>Geneva</publisher-loc>
                </element-citation>
              </ref>
              <ref id="bib26">
                <label>26</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sanchez</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Lama</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Kusunoki</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>HIV-1, sexually transmitted infections, and sexual behavior trends among men who have sex with men in Lima, Peru</article-title>
                  <source>J Acquir Immune Defic Syndr</source>
                  <volume>44</volume>
                  <year>2007</year>
                  <fpage>578</fpage>
                  <lpage>585</lpage>
                  <pub-id pub-id-type="pmid">17279049</pub-id>
                </element-citation>
              </ref>
              <ref id="bib27">
                <label>27</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alarcon</surname>
                      <given-names>JO</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Courtois</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Determinants and prevalence of HIV infection in pregnant Peruvian women</article-title>
                  <source>AIDS</source>
                  <volume>17</volume>
                  <year>2003</year>
                  <fpage>613</fpage>
                  <lpage>618</lpage>
                  <pub-id pub-id-type="pmid">12598782</pub-id>
                </element-citation>
              </ref>
              <ref id="bib28">
                <label>28</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>García</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Chavez</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Feringa</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Reproductive tract infections in rural women from the highlands, jungle, and coastal regions of Peru</article-title>
                  <source>Bull World Health Organ</source>
                  <volume>82</volume>
                  <year>2004</year>
                  <fpage>483</fpage>
                  <lpage>492</lpage>
                  <pub-id pub-id-type="pmid">15508193</pub-id>
                </element-citation>
              </ref>
              <ref id="bib29">
                <label>29</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mishra</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Barrere</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Hong</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Khan</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of bias in HIV seroprevalence estimates from national household surveys</article-title>
                  <source>Sex Transm Infect</source>
                  <volume>84</volume>
                  <year>2008</year>
                  <fpage>i63</fpage>
                  <lpage>i70</lpage>
                  <pub-id pub-id-type="pmid">18647869</pub-id>
                </element-citation>
              </ref>
              <ref id="bib30">
                <label>30</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hallett</surname>
                      <given-names>TB</given-names>
                    </name>
                    <name>
                      <surname>Stover</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Mishra</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Ghys</surname>
                      <given-names>PD</given-names>
                    </name>
                    <name>
                      <surname>Gregson</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Boerma</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Estimates of HIV incidence from household-based prevalence surveys</article-title>
                  <source>AIDS</source>
                  <volume>24</volume>
                  <year>2010</year>
                  <fpage>147</fpage>
                  <lpage>152</lpage>
                  <pub-id pub-id-type="pmid">19915447</pub-id>
                </element-citation>
              </ref>
            </ref-list>
            <sec id="sec1" sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <p id="para420">
                <supplementary-material content-type="local-data" id="ecomp10">
                  <caption>
                    <title>Supplementary appendix</title>
                  </caption>
                  <media xlink:href="mmc1.pdf"/>
                </supplementary-material>
              </p>
            </sec>
            <ack>
              <sec>
                <title>Acknowledgments</title>
                <p>This research was supported by <funding-source id="GS1">the Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative</funding-source> 059131/Z/99/Z, 078835/Z/05/Z, and 078835/Z/05/B; and <funding-source id="GS2">National Institutes of Health NIAID STD Cooperative Research Center</funding-source> AI31448 and <funding-source id="GS3">Center for AIDS Research</funding-source> P30-AI027757. The views expressed in this report are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government. We thank all men and women who participated in the surveys, interviewers, and laboratory staff. Implementation partners in our study were <funding-source id="GS4">the Peruvian STD and AIDS Control Program, Ministry of Health, National Institute of Health, National Institute of Statistics and Informatics, the US Naval Medical Research Unit Number 6</funding-source> (NAMRU-6), Roche Molecular Systems, Focus Technologies, and Gen Probe.</p>
              </sec>
            </ack>
            <ack>
              <title>Contributors</title>
              <p>CPC designed and supervised the general-population surveys. CPC and JPH supervised data analyses. PEC designed and supervised the FSW surveys. JPH supervised biostatistical aspects of study design. PJG, GPG, and KKH supervised the Peru PREVEN study. All contributed to preparing the report.</p>
            </ack>
            <ack>
              <title>The Peru PREVEN study team</title>
              <p>Antonio Bernabe-Ortiz, Clara Buendia, Fredy Canchihuaman, Marina Chiappe, Armando Cotrina, Julio Gomez, Sayda La Rosa, Patricia Segura, and Maria Valderrama (Universidad Peruana Cayetano Heredia, Peru); Anne L Buffardi, James H Jones, Pamela Kohler, Carolina Mejia, Martina Morris, Kathy K Thomas, William L H Whittington, and Ana Maria Xet-Mull (University of Washington, USA); Eric Hall and Franca Jones (US Naval Medical Research Unit Number 6 [NAMRU-6], Peru); James H Jones (Stanford University, USA); Peter White (University College London, UK); and Giovanni Quinte, Julio Evangelista, Juan Carlos Lara, Jose Tataje, Lorena Lopez-Torres, and Karina Vidarte as laboratory technicians (Universidad Peruana Cayetano Heredia, Peru).</p>
            </ack>
            <ack>
              <title>Conflicts of interest</title>
              <p>We declare that we have no conflicts of interest.</p>
            </ack>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
